AFcell Medical has obtained $2.23 million of a targeted $10 million round, which it will use for its sales and marketing team. The Pennsylvania-based startup is the maker of AmnioClear, a tissue graft derived from the placenta of living human donors that could speed recovery for tendon surgery or wound repair patients.

Full Story:

Related Summaries